The Reusable Handheld Electrolyte and Lab Technology for Humans (rHEALTH) portable in vitro diagnostic device that can run hundreds of clinical lab tests on a single drop of blood has won the $525,000 Grand Prize in the Nokia Sensing XCHALLENGE. Developed by DMI (DNA Medicine Institute; Cambridge, MA), the system can determine within minutes if the user has a cold, flu, or more serious ailment, such as pneumonia or even Ebola, with gold standard accuracy, according to contest organizers. DMI, which was one of 11 finalists in the Nokia Sensing XCHALLENGE, is also a finalist for the $10 million Qualcomm Tricorder XPRIZE.
"We are truly honored to be recognized as the Grand Prize winner in the Nokia Sensing XCHALLENGE," said DMI founder and CEO Eugene Y. Chan, MD. "To be selected from such an impressive group of worthy competitors is extremely humbling. Our hope is that the rHEALTH system, once commercialized, will enable consumers to monitor their own health while on-the-go in a more efficient manner and alert them of more serious medical concerns almost immediately."